<SEC-DOCUMENT>0001104659-23-091114.txt : 20230814
<SEC-HEADER>0001104659-23-091114.hdr.sgml : 20230814
<ACCEPTANCE-DATETIME>20230814113956
ACCESSION NUMBER:		0001104659-23-091114
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		231167578

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tekla Healthcare Opportunities Fund
		CENTRAL INDEX KEY:			0001604522
		IRS NUMBER:				465317248
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-22955
		FILM NUMBER:		231167580

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		617-772-8500

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tekla Healthcare Growth & Income Fund
		DATE OF NAME CHANGE:	20140402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tekla World Healthcare Fund
		CENTRAL INDEX KEY:			0001635977
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			MA

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-23037
		FILM NUMBER:		231167579

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		(617) 772-8515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		231167581

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	19920929
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm2323682d1_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>Washington, D.C.
20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt">SCHEDULE 14A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">Proxy Statement Pursuant
to Section&nbsp;14(a)&nbsp;of the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">(Amendment No.&nbsp;__)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Filed by a Party other than the Registrant
<FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Check the appropriate
box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: justify"><FONT STYLE="font-size: 8pt">Preliminary
                                            Proxy Statement</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="font-size: 8pt; text-align: justify"><FONT STYLE="font-size: 8pt">Confidential,
                                            for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Definitive
                                            Proxy Statement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">Definitive
                                            Additional Materials</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting
                                            Material Pursuant to Sec. 240.14a-11(c)&nbsp;or Sec. 240.14a-12</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Tekla
Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, Tekla World Healthcare<BR>
Fund</B></FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt">(Name of Registrant
as Specified In Its Charter)</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt">(Name of Person(s)&nbsp;Filing
Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Payment of Filing
Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">No
                                            fee required.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee
                                            paid previously with preliminary proxy materials.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee
                                            computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and
                                            0-11</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 16pt News Gothic MT,sans-serif; margin: 0pt 0; border-bottom: Black 6pt solid">TEKLA FUNDS ANNOUNCE ADJOURNMENT OF SPECIAL
MEETINGS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0">BOSTON, MA (August&nbsp;14, 2023) &ndash; Tekla Healthcare Investors (HQH),
Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the &ldquo;Funds&rdquo;)
today announced that their joint special meetings of shareholders on August&nbsp;14, 2023 (&ldquo;Special Meetings&rdquo;) were adjourned
until August&nbsp;29, 2023 to provide additional time for the Funds to reach a quorum on the proposal, described in their definitive joint
proxy statement dated July&nbsp;10, 2023 as filed with the Securities and Exchange Commission (the &ldquo;Proxy Statement&rdquo;), to
approve a new investment advisory agreement with abrdn,&nbsp;Inc. (the &ldquo;Proposal&rdquo;). The adjourned Special Meeting will recommence
on August&nbsp;29, 2023 at 9:00 a.m.&nbsp;EDT at the offices of the Funds, 100 Federal Street, Boston, MA. The record date for the adjourned
Special Meetings remains the same, June&nbsp;16, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0"><B><I>The shares that have been voted to date have been voted overwhelmingly
IN FAVOR of the Proposal, but a quorum for the Special Meeting has not yet been achieved.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0">At a <I>separate</I> special meeting of the Funds held on August&nbsp;14,
2023, four new trustees were elected to the Board of Trustees of each Fund, contingent upon and subject to, the approval of the Proposal
by shareholders of each Fund and the closing of the related transaction involving abrdn Inc. that is described in the Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0">During the adjournment period, the Funds will continue to solicit votes
from shareholders regarding the Proposal. Proxies previously submitted will be voted at the adjourned Special Meeting, and shareholders
who have previously submitted a proxy or otherwise voted on the Proposal need not take any action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0"><B><I>Shareholders as of the June&nbsp;16, 2023 record date who have not
yet voted on the Proposal are urged to do so promptly.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0">Shareholders may use the Proxy Card provided or may vote in the manner
set forth in the Proxy Statement. Shareholders who have questions or require voting assistance should call Okapi Partners, the Funds&rsquo;
proxy solicitor, toll-free at&nbsp;<FONT STYLE="color: red"><B>(877) 285-5990.</B></FONT>&nbsp;Representatives are available Monday -
Friday 9:00am to 10:00pm (EDT).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 12pt News Gothic MT,sans-serif; margin: 0pt 0; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><B>About Tekla</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868">Tekla is an asset manager primarily focused
on healthcare investing. Since its inception, Tekla has maintained a singular focus on the asset class. Its expertise comes from a diverse
team of individuals, many with advanced degrees in science and business, investing experience and</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: right; margin: 0pt"><FONT STYLE="font-size: 10pt"></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868">industry experience that help drive
investment decisions. &nbsp;For more information, please visit www.teklacap.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><B>About abrdn</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868">abrdn is a global investment company that
helps clients and customers plan, save and invest for the future. abrdn&rsquo;s purpose is to enable its clients to be better investors.
abrdn manages and administers &pound;500bn of assets for clients (as at 31 December&nbsp;2022). abrdn is structured around three businesses
 &ndash; Investments, Adviser and Personal &ndash; focused on their changing needs. The capabilities in abrdn&rsquo;s Investments business
are built on the strength of its insight &ndash; generated from wide-ranging research, worldwide investment expertise and local market
knowledge. abrdn&rsquo;s teams collaborate across regions, asset classes and specialisms, connecting diverse perspectives and working
with clients to identify investment opportunities that suit their needs. As at 31 December&nbsp;2022, abrdn&rsquo;s Investments business
manages &pound;376bn on behalf of clients - including insurance companies, sovereign wealth funds, independent wealth managers, pension
funds, platforms, banks and family offices. For more information, please visit www.abrdn.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><I><U>Additional Information about the Funds
and the transaction</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><I>This press release is not intended to,
and does not, solicit any proxy from any shareholder of the Funds. The solicitation of proxies to effect the transaction described herein
will only be made by a definitive proxy statement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><I>The Funds and their trustees and officers,
Tekla and its officers and employees, and other persons may be deemed to be participants in the solicitation of proxies with respect to
the approval of new investment management contracts described herein. Fund shareholders may obtain more detailed information regarding
the direct and indirect interests of a Fund&rsquo;s trustees and officers, Tekla and its officers and employees, and other persons by
reading the proxy statement relating to the transaction as filed with the Securities and Exchange Commission.&nbsp; Fund shareholders
should read the proxy statement because it contains important information.&nbsp; The proxy statement is available for free at the Securities
and Exchange Commission&rsquo;s website (www.sec.gov).</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; background-color: white; color: #686868"><I>Statements in this press release that
are not historical facts are forward-looking statements as defined by the United States securities laws. You should exercise caution in
interpreting and relying on forward-looking statements because they are subject to uncertainties and other factors that are, in some cases,
beyond a Fund&rsquo;s control and could cause actual results to differ materially from those set forth in the forward-looking statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; color: #686868">&copy; 2023 Tekla
Capital Management LLC&nbsp;|&nbsp;All rights reserved&nbsp;|&nbsp;</FONT><FONT STYLE="color: #494949"><U>Legal Disclaimer</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; color: #686868"><B>The material contained on this website is not intended to be
a recommendation or investment advice, does not constitute a solicitation to buy or sell securities, and is not provided in a fiduciary
capacity. The information provided does not take into account the specific objectives or circumstances of any particular investor, or
suggest any specific course of action. Investment decisions should be made based on an investor&rsquo;s objectives and circumstances
and in consultation with his or her advisors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; color: #686868"><I>There can be no assurance that any closed-end fund will achieve
its investment objective(s). Past performance does not guarantee future results. The net asset value of any closed-end fund will fluctuate
with the value of the underlying securities. Historically closed-end funds have often traded at a discount to their net asset value. The
distribution rate and income amounts reflect past amounts distributed and may not be indicative of future rates or income amounts. Distribution
rates and income amounts can change at any time.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; color: #686868"><B>Investors should consider the investment objective and policies,
risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information, please contact your
marketing and distribution agent, Destra Capital Advisors LLC at 877.855.3434.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Lato,sans-serif; margin: 0pt 0; color: #686868">NOT FDIC-INSURED | NOT BANK-GUARANTEED | MAY&nbsp;LOSE VALUE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
